Medical Oncology

, Volume 27, Issue 1, pp 108–113

Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life

  • Omur Karakoyun-Celik
  • Ilknur Gorken
  • Sema Sahin
  • Esmahan Orcin
  • Hilmi Alanyali
  • Munir Kinay
Original Paper

Abstract

Aim The relation of anxiety and depression levels with characteristics of coping with the disease and quality of life were evaluated in women under follow-up for breast cancer. Materials and Methods Patients who had presented to the breast cancer polyclinics for follow-up were evaluated. The Beck Depression and the State-Trait Anxiety inventories were used in the evaluation of depression and anxiety levels. In order to evaluate their power to cope with cancer, the patients were questioned for a social support network. EORTC QLQ-C30 and QLQ-BR23 questionnaires were applied for quality of life evaluations. Results There were 23 (19%) patients with depression; 3 (2.5%) with grade I anxiety, 94 (77%) grade II, and 23 (19%) grade III anxiety, respectively. Depression and anxiety levels were affected by the following parameters: being unaccompanied by spouse for hospital follow-ups (P < 0.0001); request to get help by a psychologist (P = 0.02); presence of a person to share their problems (P < 0.0001); and using an alternative treatment (P = 0.04). In the quality of life evaluations, difficulty in sleeping, emotional status, fatigue, and body appearance were related with both depression and anxiety (P < 0.05 for all), whereas physical function (P = 0.002), role performance (P = 0.005), cognitive condition (P < 0.0001), social position (P < 0.0001), pain (P < 0.0001), general health (P < 0.0001), treatment methods (P = 0.001), future anxiety (P < 0.0001), and arm symptoms (P = 0.001) were negatively affected in patients with depression. Conclusion High depression and anxiety levels in patients under follow-up for breast cancer influence the coping with cancer and quality of life adversely.

Keywords

Breast cancer Depression Anxiety Quality of life Coping with breast cancer 

References

  1. 1.
    Juan HS, Kim M, Shankar S, Han W. Predictors of adherence to screening mammography among Korean American women. Prev Med. 2004;39(3):474–81. doi:10.1016/j.ypmed.2004.05.006.CrossRefGoogle Scholar
  2. 2.
    Ahmad F, Stewart DE. Predictors of clinical breast examination among South Asian immigrant women. J Immigr Health. 2004;6(3):119–26. doi:10.1023/B:JOIH.0000030227.41379.13.CrossRefPubMedGoogle Scholar
  3. 3.
    Sağlık Bakanlığı—Sağlık İstatistikleri TC 2002. Kadınlarda görülen ilk 10 kanser türü 14.03.2006 http://www.saglik.gov.tr/sb/extras/istatistikler/apk_2002/apk_2002pdf.
  4. 4.
    Coyne JC, Palmer SC, Shapiro PJ, Thompson R, DeMichele A. Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry. 2004;26(2):121–8. doi:10.1016/j.genhosppsych.2003.08.012.CrossRefPubMedGoogle Scholar
  5. 5.
    Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751–7. doi:10.1001/jama.249.6.751.CrossRefPubMedGoogle Scholar
  6. 6.
    Beck AT, Guthy D, Steer RA, Ball R. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984;40:1365–7. doi:10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D.CrossRefPubMedGoogle Scholar
  7. 7.
    Spielberger CD, Gorsuch RL, Lushene RD. STAI manual. Palto Alto, CA: Consulting Psychologist Press; 1970.Google Scholar
  8. 8.
    Hisli N. Beck Depresyon Envateri’nin geçerliliği üzerine bir çalışma. Turk Psikoloji Dergisi. 1988;22:118–26.Google Scholar
  9. 9.
    Tegin B Depresyonda bilissel bozukluklar: Beck modeline gore bir inceleme. Non-published Doctorate Dissertation. Ankara: Psychology Department, Hacettepe University; 1980.Google Scholar
  10. 10.
    LeCompte A, Öner N. Durumluk—sürekli kaygı envanterinin Türkçe’ye adaptasyon ve standardizasyonu ile ilgili bir çalışma. IX. Milli psikiyatri ve nörolojik bilimler kongresi çalışmaları 1975; 457–462.Google Scholar
  11. 11.
    Aaronson NK. The European organization for research of treatment of cancer QLQ-C30. Quality of life instrument use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76. doi:10.1093/jnci/85.5.365.CrossRefPubMedGoogle Scholar
  12. 12.
    Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.PubMedGoogle Scholar
  13. 13.
    Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30. Eur J Cancer Care (Engl). 2004;13(2):135–44. doi:10.1111/j.1365-2354.2003.00435.x.CrossRefGoogle Scholar
  14. 14.
    Hoopman R, Muller MJ, Terwee CB, et al. Translation and validation of the EORTCQLQ-C30 for use among Turkish and Moroccan ethnicminority cancer patients in the Netherlands. Eur J Cancer. 2006;42(12):1839–47.CrossRefPubMedGoogle Scholar
  15. 15.
    Vickberg SMJ. Fears about breast cancer recurrence. Cancer Pract. 2001;9(5):237–43. doi:10.1046/j.1523-5394.2001.009005237.x.CrossRefGoogle Scholar
  16. 16.
    Schidmit-Büchi S, Halfens RJ, Dassen T, van den Borne B. A review of psychosocial needs of breast-cancer patients and their relatives. J Clin Nurs. 2008;17(21):2895–909. doi:10.1111/j.1365-2702.2008.02490.x.CrossRefGoogle Scholar
  17. 17.
    Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Qual Life Res. 2005;14(8):1825–33. doi:10.1007/s11136-005-4324-3.CrossRefPubMedGoogle Scholar
  18. 18.
    Ell K, Xie B, Wells A, Nedjat-Haiem F, Lee PJ, Vourlekis B. Economic stress among low-income women with cancer. Cancer. 2008;112(3):616–25. doi:10.1002/cncr.23203.CrossRefPubMedGoogle Scholar
  19. 19.
    Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, Yun YH. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage. 2008;35(6):644–55. Epub 2008 Mar 20. doi:10.1016/j.jpainsymman.2007.08.012.
  20. 20.
    Costanzo ES, Lutgendorf SK, Mattes ML, Trehan S, Robinson CB, Tewfik F, et al. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer. 2007;97(12):1625–31. doi:10.1038/sj.bjc.6604091.CrossRefPubMedGoogle Scholar
  21. 21.
    Dorval M, Maunsell E, Taylor-Brown J, Kilpatrick M. Marital stability after breast cancer. J Natl Cancer Inst. 1999;91(1):54–9. doi:10.1093/jnci/91.1.54.CrossRefPubMedGoogle Scholar
  22. 22.
    Kadmon I, Ganz FD, Rom M, Woloski-Wruble AC. Social, marital, and sexual adjustment of Israeli men whose wives were diagnosed with breast cancer. Oncol Nurs Forum. 2008;35(1):131–5. doi:10.1188/08.ONF.131-135.CrossRefPubMedGoogle Scholar
  23. 23.
    Dorval M, Guay S, Mondor M, Mâsse B, Falardeau M, Robidoux A, et al. Couples who get closer after breast cancer: frequency and predictors in a prospective investigation. J Clin Oncol. 2005;23(15):3588–96. doi:10.1200/JCO.2005.01.628.CrossRefPubMedGoogle Scholar
  24. 24.
    Taylor-Brown J, Kilpatrick M, Maunsell E, Dorval M. Partner abandonment of women with breast cancer Myth or reality? Cancer Pract. 2000;8(4):160–4. doi:10.1046/j.1523-5394.2000.84004.x.CrossRefPubMedGoogle Scholar
  25. 25.
    Rees CE, Bath PA. Exploring the information flow: partners of women with breast cancer, patients, and healthcare professionals. Oncol Nurs Forum. 2000;27(8):1267–75.PubMedGoogle Scholar
  26. 26.
    Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: A European survey. Ann Oncol. 2005;16:655–63. doi:10.1093/annonc/mdi110.CrossRefPubMedGoogle Scholar
  27. 27.
    Ceylan S, Hamzaoglu O, Komurcu S, et al. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med. 2002;10:94–9. doi:10.1054/ctim.2002.0527.CrossRefPubMedGoogle Scholar
  28. 28.
    Rakovitch E, Pignol JP, Chartier C, Ezer M, Verma S, Dranitsaris G, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat. 2005;90(2):139–48. doi:10.1007/s10549-004-3779-1.CrossRefPubMedGoogle Scholar
  29. 29.
    Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340(22):1733–9. doi:10.1056/NEJM199906033402206.CrossRefPubMedGoogle Scholar
  30. 30.
    Eschiti VS. Complementary and alternative modalities used by women with female-specific cancers. Holist Nurs Pract 2008; 22(3):127–38; quiz 139.Google Scholar
  31. 31.
    Bullinger M. Measuring health related quality of life. An international perspective. Adv Exp Med Biol. 2003;528:113–22. doi:10.1007/0-306-48382-3_23.CrossRefPubMedGoogle Scholar
  32. 32.
    Shim EJ, Mehnert A, Koyama A, Cho SJ, Inui H, Paik NS, et al. Health-related quality of life in breast cancer: A cross-cultural survey of German, Japanese, and South Korean patients. Breast Cancer Res Treat. 2006;99(3):341–50. doi:10.1007/s10549-006-9216-x.CrossRefPubMedGoogle Scholar
  33. 33.
    Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjödén PO. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer. 1991;27(9):1075–81.CrossRefPubMedGoogle Scholar
  34. 34.
    Krishnan L, Stanton AL, Collins CA, Liston VE, Jewell WR. Form or function? Part 2. Objective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer. 2001;91(12):2282–7. doi:10.1002/1097-0142(20010615)91:12<2282::AID-CNCR1259>3.0.CO;2-0.CrossRefPubMedGoogle Scholar
  35. 35.
    Holzner B, Kemmler G, Kopp M, Moschen R, Schweigkofler H, Dünser M, et al. Quality of life in breast cancer patients-not enough attention for long-term survivors? Psychosomatics. 2001;42(2):117–23. doi:10.1176/appi.psy.42.2.117.CrossRefPubMedGoogle Scholar
  36. 36.
    Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21(22):4184–93. doi:10.1200/JCO.2003.04.196.CrossRefPubMedGoogle Scholar
  37. 37.
    Burke MB. Sexuality, sexual dysfunction, and cancer. In: Varricchio C, Pierce M, Walker CL, Ades TB, editors. A cancer source book for nurses. Atlanta: American Cancer Society; 1997. p. 231–44.Google Scholar
  38. 38.
    Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16:501–14.PubMedGoogle Scholar
  39. 39.
    Ganz PA, Litwin MS, Meyerowitz BE. Sexual problems. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 3032–48.Google Scholar
  40. 40.
    Knobf MT. Natural menopause and ovarian toxicity associated with breast cancer therapy. Oncol Nurs Forum. 1998;25:1519–30.PubMedGoogle Scholar
  41. 41.
    Lamb MA. Sexuality and sexual functioning. In: McCorkle R, Grant M, Frank-Stromborg M, Baird SB, editors. Cancer nursing—a comprehensive textbook. 2nd ed. Philadelphia: W.B. Saunders Company; 1996. p. 1105–27.Google Scholar
  42. 42.
    Schover LR. The impact of breast cancer on sexuality, body image, and intimate relationships. CA Cancer J Clin. 1991;41:112–20. doi:10.3322/canjclin.41.2.112.CrossRefPubMedGoogle Scholar
  43. 43.
    Shell JA. Evidence-based practice for symptom management in adults with cancer: sexual dysfunction. Oncol Nurs Forum. 2002;29(1):53–66. doi:10.1188/02.ONF.53-69.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2009

Authors and Affiliations

  • Omur Karakoyun-Celik
    • 1
    • 3
  • Ilknur Gorken
    • 2
  • Sema Sahin
    • 2
  • Esmahan Orcin
    • 2
  • Hilmi Alanyali
    • 2
  • Munir Kinay
    • 2
  1. 1.Department of Radiation OncologyCelal Bayar University Medical SchoolManisaTurkey
  2. 2.Department of Radiation OncologyDokuz Eylul University Medical SchoolIzmirTurkey
  3. 3.IzmirTurkey

Personalised recommendations